Table 2.

FLIO Lifetimes in Patients with CHM

Variable	Healthy Controls (n = 14 Eyes)	CHM Patients (n = 14 Eyes)	P
Age (y), mean ± SD	28 ± 14	28 ± 14	0.989
Lifetimes (ps), mean ± SD
Fovea (area C)
SSC	96 ± 32	153 ± 74	<0.05*
LSC	173 ± 39	222 ± 90	0.075
Hyperfluorescent area (CHM)/IR (healthy)
SSC	157 ± 42	283 ± 55	<0.001*
LSC	212 ± 38	349 ± 50	<0.001*
Hypofluorescent area (CHM)/OR (healthy)
SSC	183 ± 40	362 ± 84	<0.001*
LSC	232 ± 40	419 ± 64	<0.001*
Atrophic area (CHM)/OR (healthy)
SSC	183 ± 39	632 ± 209	<0.001*
LSC	232 ± 40	680 ± 198	<0.001*

Statistical analysis of FLIO lifetimes in patients with CHM compared to healthy controls. Areas C, IR, and OR correspond to the central circle, inner macular ring, and outer macular ring on the standardized ETDRS grid, respectively.

^*Indicates significance. P < 0.05 was considered significant.